• Bertha Kalifon Madras


Of all the neurotransmitter systems in the brain, dopamine (DA) has been the most widely explored. The reason becomes apparent when one considers the evidence for dopamine involvement in neurological,1 psychiatric,2 and endocrinological function.3


Dopamine Receptor Adenylate Cyclase Dopamine Agonist Tardive Dyskinesia Neuroleptic Drug 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bernheimer, H., Birkmayer, W., Hornykiewicz, O., Jellinger, K., and Seitelberger, F., 1973, J. Neurol. Sci. 20:415–455.PubMedGoogle Scholar
  2. 2.
    Seeman, P., 1977, Biochem. Pharmacol. 26:1741–1748.PubMedGoogle Scholar
  3. 3.
    Lichtensteiger, W., 1979, The Neurobiology of Dopamine (A. S. Horn, J. Korf, and B. H. C. Westerink, eds.), Academic Press, New York, pp. 491–521.Google Scholar
  4. 4.
    Ehringer, H., and Hornykiewicz, O., 1960, Klin. Wochenscher. 38:1236–1239.Google Scholar
  5. 5.
    Birkmayer, W., and Hornykiewicz, O., 1962, Arch. Psychiatr. Nervekr. 203:560–574.Google Scholar
  6. 6.
    Horn, A. S., Korf, J., and Westerink, B. H. C. (eds.), 1979, The Neurobiology of Dopamine ,Academic Press, New York.Google Scholar
  7. 7.
    Iversen, L. L., Iversen, S. D., and Snyder, S. H. (eds.), 1975, Handbook of Psychopharmacology ,Volume 3, Plenum Press, New York.Google Scholar
  8. 8.
    Costa, E., and Greengard, P. (eds.), 1978, Advances in Biochemical Psychopharmacology ,Volume 19, Raven Press, New York.Google Scholar
  9. 9.
    Van Rossum, J. M., 1966, Arch. Int. Pharmacodyn. Ther. 160:492–494.PubMedGoogle Scholar
  10. 10.
    Matthysse, S., 1974, J. Psychiatr. Res. 11:107–113.PubMedGoogle Scholar
  11. 11.
    Nyback, H., Sedvall, G., and Kopin, I. J., 1967, Life Sci. 6:2307–2312.PubMedGoogle Scholar
  12. 12.
    Gallagher, J. P., Inokuchi, H., and Shinnick-Gallagher, P., 1980, Nature 283:770–772.PubMedGoogle Scholar
  13. 13.
    Gruen, P. H., Sachar, E. H., Langer, G., Altman, N., Leifer, M., Frantz, A., and Halpern, F. S., 1978, Arch. Gen. Psychiatry 35:108–116.PubMedGoogle Scholar
  14. 14.
    Kebabian, J. W., Petzold, G. L., and Greengard, P., 1972, Proc. Natl. Acad. Sci. U.S.A. 69:2145–2149.PubMedGoogle Scholar
  15. 15.
    Iversen, L. L., 1975, Science 188:1084–1089.PubMedGoogle Scholar
  16. 16.
    Seeman, P., Lee, T., Chau-Wong, M., and Wong K., 1976, Nature 261:717–719.PubMedGoogle Scholar
  17. 17.
    Creese, I., Burt, D. R., and Snyder, S. H., 1976, Science 192:481–483.PubMedGoogle Scholar
  18. 18.
    Seeman, P., 1980, Pharmacol. Rev. 32:229–313.PubMedGoogle Scholar
  19. 19.
    Welsh, J., 1972, Catecholamines (H. Blashko and E. Muscholl, eds.), Springer-Verlag, Berlin, pp. 79–109.Google Scholar
  20. 20.
    Cottrell, G. A., Berry, M. S., and Macon, J. B., 1974, Neuropharmacology 13:431–439.PubMedGoogle Scholar
  21. 21.
    Ginsborg, B. L., House, C. P., and Turnbull, K. W., 1976, Br. J. Pharmacol. 57:133–140.PubMedGoogle Scholar
  22. 22.
    Holzbauer, M., and Sharman, D. F., 1979, The Neurobiology of Dopamine (A. S. Horn, J. Korf, and B. H. C. Westerink, eds.), Academic Press, New York, pp. 357–379.Google Scholar
  23. 23.
    Lackovic, Z., Relja, M., and Neff, N. H., 1982, J. Neurochem. 38:1453–1458.PubMedGoogle Scholar
  24. 24.
    Weil-Malherbe, H., and Bone, A. D., 1957, Nature 180:1050.PubMedGoogle Scholar
  25. 25.
    Carlsson, A., and Waldeck, B., 1958, Acta Physiol. Scand. 44:293–298.PubMedGoogle Scholar
  26. 26.
    Birkmayer, W., and Hornykiewicz, O., 1961, Wien. Klin. Wochenschr. 73:787–788.PubMedGoogle Scholar
  27. 27.
    Hokfelt, T., Fuxe, K., and Goldstein, M., 1975, Ann. N.Y. Acad. Sci. 254:407–432.PubMedGoogle Scholar
  28. 28.
    Bell, C., and Gillespie, J. S., 1981, J. Neurochem. 36:703–706.PubMedGoogle Scholar
  29. 29.
    Bell, C., 1982, Neuroscience 7:1–8.PubMedGoogle Scholar
  30. 30.
    Taylor, K., and Laverty, R., 1969, J. Neurochem. 16:1361–1366.PubMedGoogle Scholar
  31. 31.
    Westerink, B. H. C., and Korf, J., 1977, J. Neurochem. 29:697–706.PubMedGoogle Scholar
  32. 32.
    Westerink, B. H. C., and Korf, J., 1976, Eur. J. Pharmacol. 38:281–291.PubMedGoogle Scholar
  33. 33.
    Costa, E., Koslow, S. H., and LeFevre, H. F., 1975, Handbook of Psychopharmacology ,Volume 1 (L. L. Iversen, S. D. Iversen, and S. H. Snyder, eds.), Plenum Press, New York, pp. 1–24.Google Scholar
  34. 34.
    Coyles, J. T., and Henry, D., 1973, J. Neurochem. 21:61–67.Google Scholar
  35. 35.
    Ponzio, F., Achilli, G., and Algeri, S., 1981, J. Neurochem. 36:1361–1367.PubMedGoogle Scholar
  36. 36.
    Westerink, B. H. C., and Mulder T. B. A., 1981, J. Neurochem. 36:1449–1462.PubMedGoogle Scholar
  37. 37.
    Magnusson, O., Nilsson, R. B., and Westerlund, D., 1980, J. Chromatogr. 221:237–247.PubMedGoogle Scholar
  38. 38.
    Kempf, E., and Mandel, P., 1981, Anal. Biochem. 112:223–231.PubMedGoogle Scholar
  39. 39.
    Brownstein, M., Saavedra, J. M., and Palkovits, M., 1974, Brain Res. 79:431–436.PubMedGoogle Scholar
  40. 40.
    Versteeg, D. H. G., van der Gugten, J., de Jong, W., and Palkovits, M., 1976, Brain Res. 113:563–574.PubMedGoogle Scholar
  41. 41.
    Falck, B., Hillarp, N. A., Thieme, G., and Torp, A., 1962, J. Histochem. Cytochem. 10:348–354.Google Scholar
  42. 42.
    Axelsson, S., Bjorklund, A., Falck, B., Lindvall, O., and Svensson, L.-A., 1973, Acta Physiol. Scand. 87:57–62.PubMedGoogle Scholar
  43. 43.
    Lindvall, O., Bjorklund, A., Hokfelt, T., and Lungdahl, A., 1973, Histochemie 35:31–38.PubMedGoogle Scholar
  44. 44.
    Anden, N.-E., Carlsson, A., Dahlstrom, A., Fuxe, K., Hillarp, N. A., and Larsson, N., 1964, Life Sci. 3:523–530.PubMedGoogle Scholar
  45. 45.
    Ungerstedt, U., 1971, Acta Physiol. Scand. [Suppl.] 82:1–93.Google Scholar
  46. 46.
    Dahlstrom, A., and Fuxe, K., 1964, Acta Physiol. Scand. [Suppl.] 232:1–55.Google Scholar
  47. 47.
    Lindvall, O., 1975, Brain Res. 87:89–95.PubMedGoogle Scholar
  48. 48.
    Bjorklund, A., Falck, B., Hromek, F., Owman, C., and West, K. A., 1970, Brain Res. 17:1–23.PubMedGoogle Scholar
  49. 49.
    Moore, R. Y. and Bloom, F. E. 1978, Ann Rev. Neurosci. 1:129–169.PubMedGoogle Scholar
  50. 50.
    Udenfriend, S., and Zaltzman-Nirenberg, P., 1963, Science 142:394–396.PubMedGoogle Scholar
  51. 51.
    Nyback, H., Sedvall, G., Sjoquist, B., and Wiesel, F.-A., 1973, Acta Physiol. Scand. 87:8A–9A.Google Scholar
  52. 52.
    Kucaenski, R. J., and Mandell, A. J., 1972, J. Biol. Chem. 247:3114–3122.Google Scholar
  53. 53.
    Besson, M. J., Cheramy, A., Gauchy, C., and Musacchio, J., 1973, Eur. J. Pharmacol. 22:181–186.PubMedGoogle Scholar
  54. 54.
    Murrin, L. C., Morgenroth, V. H. III, and Roth, R. H., 1976, Mol. Pharmacol. 12:1070–1081.PubMedGoogle Scholar
  55. 55.
    Goldstein, M., Bronaugh, R. L., Ebstein, B., and Roberge, C., 1976, Brain Res. 109:563–574.PubMedGoogle Scholar
  56. 56.
    Nowycky, M. C., and Roth, R. H., 1978, Prog. Neuropsychopharmacol. 2:139–158.Google Scholar
  57. 57.
    Guidotti, A., and Costa, E., 1977, Biochem. Pharmacol. 26:817–823.PubMedGoogle Scholar
  58. 58.
    Carlsson, A., and Lindqvist, M., 1978, Naunyn Schmiedebergs Arch. Pharmacol. 303:157–164.PubMedGoogle Scholar
  59. 59.
    Sved, A. F., Fernstrom, J. D., and Wurtman, R. J., 1979, Life Sci. 25:1293–1300.PubMedGoogle Scholar
  60. 60.
    Roth, R. H., 1979, The Neurobiology of Dopamine (A. S. Horn, J. Korf, and B. H. C. Westerink, eds.), Academic Press, New York, pp. 101–122.Google Scholar
  61. 61.
    Musacchio, J. M., 1975, Handbook of Psychopharmacology (L. L. Iversen, S. D. Iversen, and S. H. Snyder, eds.), Plenum Press, New York, pp. 4–10.Google Scholar
  62. 62.
    Nagatsu, T., Levitt, M., and Udenfriend, S., 1974, J. Biol. Chem. 239:2910–2917.Google Scholar
  63. 63.
    Waymire, J. C., Bjur, R., and Weiner, N., 1971, Anal. Biochem. 43:588–600.PubMedGoogle Scholar
  64. 64.
    Sourkes, T. L., 1955, Rev. Can. Biol. 14:49–63.PubMedGoogle Scholar
  65. 65.
    Sourkes, T. L., 1966, Pharmacol. Rev. 18:53–116.PubMedGoogle Scholar
  66. 66.
    Carlsson, A., and Lindqvist, M., 1973, J. Neural. Transm. 23:79–91.Google Scholar
  67. 67.
    De Belleroche, J. S., Bradford, H. F., and Jones, D. G., 1976, J. Neurochem. 26:561–571.PubMedGoogle Scholar
  68. 68.
    Liang, N. Y., and Rutledge, C. O., 1982, Biochem. Pharmacol. 31:983–992.PubMedGoogle Scholar
  69. 69.
    Dubocovich, M. L., and Weiner, N., 1981, J. Pharmacol Exp. Ther. 219:710–717.Google Scholar
  70. 70.
    Giorguieff-Chesselet, M. F., Kemel, M. L., Wandscheer, D., and Glowinski, J., 1979, Eur. J. Pharmacol. 60:101–104.Google Scholar
  71. 71.
    Roberts, R. J., and Anderson, S. D., 1979, J. Neurochem. 32:1539.PubMedGoogle Scholar
  72. 72.
    Ennis, C., Kemp, J. D., and Cox, B., 1981, J. Neurochem. 36:1515–1520.PubMedGoogle Scholar
  73. 73.
    Bustos, G., and Roth, R. H., 1972, Br. J. Pharmacol. 46:101–115.PubMedGoogle Scholar
  74. 74.
    Holz, R. W., and Coyle, J. T., 1974, Mol. Pharmacol. 10:746–758.Google Scholar
  75. 75.
    Heikkila, R. E., Orlansky, W., and Cohen, G., 1975, Biochem. Pharmacol. 24:847–852.PubMedGoogle Scholar
  76. 76.
    Westerink, B. H. C., 1979, The Neurobiology ofDopamine (A. Horn, J. Korf, and B. Westerink, eds.), Academic Press, New York, pp. 225–291.Google Scholar
  77. 77.
    Westerink, B. H. C., and Spaan, S. J., 1982, J. Neurochem. 38:680–686.PubMedGoogle Scholar
  78. 78.
    Carlsson, A., and Lindqvist, M., 1963, Acta Pharmacol. Toxicol. 20:140–144.Google Scholar
  79. 79.
    Anden, N.-E., and Stock, G., 1973, J. Pharm. Pharmacol. 25:346–348.PubMedGoogle Scholar
  80. 80.
    Bacopoulos, N. G., Heninger, G. R., and Roth, A. H., 1978, Life Sci. 23:1805–1812.PubMedGoogle Scholar
  81. 81.
    Costall, B., and Naylor, R. J., 1973, Arzneim. Forsch. 23:674–683.Google Scholar
  82. 82.
    Ezrin-Waters, C., Muller, P., and Seeman, P., 1976, Can. J. Physiol. Pharmacol. 54:516–519.Google Scholar
  83. 83.
    Snyder, S. H., 1976, Am. J. Psychiatry 133:197–202.PubMedGoogle Scholar
  84. 84.
    Goodwin, F. K., 1972, Psychiatric Complications of Medical Drugs ,(R. I. Shader, ed.), Raven Press, New York, pp. 149–174.Google Scholar
  85. 85.
    Smythe, G. A., 1977, Clin. Endocrinol. 7:325–341.Google Scholar
  86. 86.
    Dill, R. E., Jones, D. L., Christian Gillin, J., and Murphy G., 1979, Pharmacol. Biochem. Behav. 20:711–716.Google Scholar
  87. 87.
    Niemegeers, C. J. E., Heykants, J. J. P., and Janssen, P. A. J., 1981, Psychopharmacology 75:240–244.PubMedGoogle Scholar
  88. 88.
    Ungerstedt, U., 1971, Acta Physiol. Scand. [Suppl.] 367:69–93.Google Scholar
  89. 89.
    Ungerstedt, U., 1971, Ibid 49–68.Google Scholar
  90. 90.
    Corrodi, H., Farnebo, L., Fuxe, K., Hamberger, B., and Ungerstedt, U., Eur. J. Pharmacol. 20:195–201.Google Scholar
  91. 91.
    Siggins, G. R., 1978, Psychopharmacology: A Generation of Progress (M. A. Lipton, A. Di Mascio, and K. F. Killam, eds.), Raven Press, New York, pp. 143–157.Google Scholar
  92. 92.
    Feltz, P., and De Champlain, J., 1972, Brain Res. 43:601–605.PubMedGoogle Scholar
  93. 93.
    Herz, A., and Zieglgansberger, W., 1968, Int. J. Neuropharmacol. 7:221–230.PubMedGoogle Scholar
  94. 94.
    York, D.-H., 1975, Handbook of Psychopharmacology ,Volume 6 (L. L. Iversen, S. D. Iversen, and S. H. Snyder, eds.), Plenum Press, New York, pp. 23–61.Google Scholar
  95. 95.
    Kebabian, J. W., and Calne, D. B., 1979, Nature 277:93–96.PubMedGoogle Scholar
  96. 96.
    Brown, E. H., Carroll, R. J., and Aurbach, G.D., 1977, Proc. Natl. Acad. Sci. U. S. A. 74:4210–4213.PubMedGoogle Scholar
  97. 97.
    Sokoloff, P., Martres, M. P., and Schwartz, J. C., 1980, Naunyn Schmiedebergs Arch. Pharmacol. 315:89–102.PubMedGoogle Scholar
  98. 98.
    Goldberg, L. I., and Kohli, J. D., 1979, Commun. Psychopharmacol. 3:447–456.PubMedGoogle Scholar
  99. 99.
    Leysen, J. E., and Gommeren, W., 1978, Life Sci. 23:447–452.PubMedGoogle Scholar
  100. 100.
    Kebabian, J. W., and Greengard, P., 1971, Science 174:1346–1349.PubMedGoogle Scholar
  101. 101.
    Stoof, J. C., Kebabian, J. W., 1981, Nature 294:366–368.PubMedGoogle Scholar
  102. 102.
    Hyttel, J., 1980, Psychopharmacology 67:107–109.PubMedGoogle Scholar
  103. 103.
    Cross, A. J., and Owen, F., 1980, Eur. J. Pharmacol. 65:341–347.PubMedGoogle Scholar
  104. 104.
    Hyttel, J., 1978, Life Sci. 23:551–556.PubMedGoogle Scholar
  105. 105.
    Garau, L., Govoni, S., Stefanini, E., Trabucchi, M., and Spano, P. F., 1978, Life Sci. 23:1745–1750.PubMedGoogle Scholar
  106. 106.
    Minneman, K. P., Quik, M., and Emson, P. C., 1978, Brain Res. 151:507–521.PubMedGoogle Scholar
  107. 107.
    Cannon, J. G., Costall, B., Laduron, P. M., Leysen, J. E., Naylor, R. J., 1978 Biochem. Pharm. 27:1417–1420.PubMedGoogle Scholar
  108. 108.
    Iversen, L. L., Horn, A. S., and Miller, R. J., 1975, Adv. Neurol. 9:197–212.PubMedGoogle Scholar
  109. 109.
    Markstein, A. M., Herrling, P. L., Burki, H. R., Asper, H., and Ruch, W., 1978, J. Neurochem. 31:1163–1172.PubMedGoogle Scholar
  110. 110.
    Pagnini, G., Camanni, F., Crispino, A., and Portaleone, P., 1978, J. Pharm. Pharmacol. 30:92–95.PubMedGoogle Scholar
  111. 111.
    Leysen, J., and Laduron, P., 1977, Life Sci. 20:281–288.PubMedGoogle Scholar
  112. 112.
    Quik, M., and Iversen, L. L., 1979, Eur. J. Pharmacol. 56:323–330.PubMedGoogle Scholar
  113. 113.
    Watling, K. J., Dowling, J. E., and Iversen, L. L., 1979, Nature 281:578–580.PubMedGoogle Scholar
  114. 114.
    Tassin, J. P., Simon, H., Herve, D., Blanc, G., Le Moal, M., and Bockaert, J., 1982, Nature 295:696–698.PubMedGoogle Scholar
  115. 115.
    Church, A. C., Bunney, B. S., and Krieger, N. R., 1982, Brain Res. 234:369–376.PubMedGoogle Scholar
  116. 116.
    Hartley, E., Spuhler, K., Prasad, K. N., and Seeman, P., 1980, Brain Res. 190:574–577.PubMedGoogle Scholar
  117. 117.
    Premont, J., Thierry, A. M., Tassin, J. P., Glowinski, J., Blanc, G., and Bockaert, J., 1976, FEBS Lett. 68:99–104.PubMedGoogle Scholar
  118. 118.
    McSwigon, J. D., Nichol, S. E., Gottesman, I. I., Tuason V. B., and Frey, W. H. II, 1980, J. Neurochem. 34:594–601.Google Scholar
  119. 119.
    Thomas, T. N., and Zemp, J. W., 1977, J. Neurochem. 28:663–665.PubMedGoogle Scholar
  120. 120.
    Kayaalp, S. O., Rukensteen, J. S., and Neff, N. H., 1981, Neuropharmacology 20:409–410.Google Scholar
  121. 121.
    Madras, B. K., Davis, A., Chan, B., and Seeman, P., 1981, Prog. Neuropyschopharmacol. 5:543–548.Google Scholar
  122. 122.
    Madras, B. K., and Chan, B., 1983, CNS Receptors, From Molecular Pharmacology to Behavior. (P. Mandel and F. V. DeFeudis, eds.), Raven Press, pp. 275–287.Google Scholar
  123. 123.
    Heikilla, R. E., Cabbat, F. S., and Manzino, L., 1981, Res. Commun. Chem. Pathol. Phar macol. 34:409–421.Google Scholar
  124. 124.
    Kebabian, J. W., 1978, Adv. Biochem. Psychopharmacol. 19:131–154.PubMedGoogle Scholar
  125. 125.
    Lee, T., Seeman, P., Tourtellotte, W. W., Farley, I. J., and Hornykiewicz, O., 1978, Nature 274:897–900.PubMedGoogle Scholar
  126. 126.
    Crow, T. J., Johnstone, E. C., Longden, A. J., and Owen, F., 1978, Life Sci. 23:563–568.PubMedGoogle Scholar
  127. 127.
    Peroutka, S. J., U’Prichard, D. C., Greenberg, D. A., and Snyder, S. H., 1977, Neuropharmacology 16:549–556.PubMedGoogle Scholar
  128. 128.
    Leysen, J. E., Niemegeers, C. J. E., Tollenaere, J. P., and Laduron P. M., 1978, Nature 272:168–171.PubMedGoogle Scholar
  129. 129.
    Seeman, P., Westman, K., Coscina, D., and Warsh, J. J., 1980, Eur. J. Pharmacol. 66:179–191.PubMedGoogle Scholar
  130. 130.
    Quik, M., and Iversen, L. L., 1979, Eur. J. Pharmacol. 56:323–330.PubMedGoogle Scholar
  131. 131.
    Seeman, P., Chau-Wong, M., Tedesco, J., and Wong, D., 1975, Proc. Natl. Acad. Sci. U.S.A. 72:4376–4380.PubMedGoogle Scholar
  132. 132.
    Spedding, M., and Berg, C., 1982, J. Pharm. Pharmacol. 34:56–58.PubMedGoogle Scholar
  133. 133.
    List, S., and Seeman, P., 1981, Proc. Natl. Acad. Sci. U.S.A. 78:2620–2624.PubMedGoogle Scholar
  134. 134.
    Quik, M., Iversen, L. L., Larder, A., and Mackay, A. V. P., 1978, Nature 274:513–514.PubMedGoogle Scholar
  135. 135.
    Baudry, M., Martres, M. P., and Schwartz, J. C., 1979, Naunyn Schmiedebergs Arch. Pharmacol. 308:231–237.PubMedGoogle Scholar
  136. 136.
    Lazareno, S., Nahorski, S. R., 1981, Br. J. Pharmacol. 74:231P–232P.Google Scholar
  137. 137.
    Freedman, S. B., Poat, J. A., and Woodruff, G. N., 1981, Neuropharmacology 20:1323–1326.PubMedGoogle Scholar
  138. 138.
    Jenner, P., and Marsden, C. D., 1981, Neuropharmacology 20:1285–1293.PubMedGoogle Scholar
  139. 139.
    Theodourou, A. E., Hall, M. D., Jenner, P., and Marsden, C. D., 1980, J. Pharm. Pharmacol. 32:441–444.Google Scholar
  140. 140.
    Seeman, P., Ulpian, C., and Wells, J., 1982, Soc. Neurosci. Abstr. 8:718.Google Scholar
  141. 141.
    Sibley, D. R., DeLean, A., and Creese, I., 1982, J. Biol. Chem. 257:6351–6361.PubMedGoogle Scholar
  142. 142.
    Stefanini, E., and Clement-Cormier, Y. C., 1981, Eur. J. Pharmacol. 74:257–260.Google Scholar
  143. 143.
    Thai, L., Mishra, R. K., Gardner, E. L., Horowitz, S. G., Varmuza, S., and Makman, M. H., 1979, Brain Res. 170:381–386.Google Scholar
  144. 144.
    Murrin, L. C., Gale, K., and Kuhar, M. J., 1979, Eur. J. Pharmacol. 60:229–235.PubMedGoogle Scholar
  145. 145.
    Schwarcz, R., Creese, I., Coyle, J. T., and Snyder, S. H., 1978, Nature 271:766–768.PubMedGoogle Scholar
  146. 146.
    Sibley, D. R., and Creese, I., 1980, Endocrinology 107:1405–1409.PubMedGoogle Scholar
  147. 147.
    George, S. R., Watanabe, M., and Seeman, P., 1983, in, Dopamine Receptors (C. Kaiser and J. Kebabian, eds.) American Chemical Society, Washington, D.C., pp 93–99.Google Scholar
  148. 148.
    Creese, I., Usdin, T., and Snyder, S. H., 1979, Nature 278:557–578.Google Scholar
  149. 149.
    Hamblin, M. W., and Creese, I., 1982, Mol. Pharmacol. 21:52–56.PubMedGoogle Scholar
  150. 150.
    Leslie, F. H., Dunlop, C. E., and Cox, B. M., 1980, J. Neurochem. 34:219–221.PubMedGoogle Scholar
  151. 151.
    Heikilla, R. E., Cabbat, F. S., and Manzino, L., 1982, J. Neurochem. 38:1000–1006.Google Scholar
  152. 152.
    Muakkassah-Kelly, S. F., Andersen, J. W., Shih, J. C., and Hochstein, P., 1982, Biochem. Biophys. Res. Commun. 104:1003–1010.PubMedGoogle Scholar
  153. 153.
    Tolbert, L. C., Thomas, T. N., Middaugh, J. D., and Zemp, J. W., 1979, Brain Res. Bull. 4:43–48.PubMedGoogle Scholar
  154. 154.
    Hamblin, M. W., and Creese, I., 1982, Life Sci. 30:1587–1595.PubMedGoogle Scholar
  155. 155.
    Meltzer, H. Y., and So, R., 1979, Life Sci. 25:531–536.PubMedGoogle Scholar
  156. 156.
    Muller, E. E., Stefanini, E., Camanni, F., Locatelli, V., Massara, F., Spano, P. F., and Cochi, D., 1979, J. Neural Transm. 46:205–214.PubMedGoogle Scholar
  157. 157.
    Cronin, M. J., and Weiner, R. I., 1979, Endocrinology 104:307–312.PubMedGoogle Scholar
  158. 158.
    Laduron, P. M., Janssen, P. F. M., and Leysen, J. E., 1978, Biochem. Pharmacol. 27:317–321.PubMedGoogle Scholar
  159. 159.
    Köhler, C., Fuxe, K., and Ross, S. B., 1981, Eur. J. Pharmacol. 72:397–402.PubMedGoogle Scholar
  160. 160.
    Klemm, N., Murrin, L. C., and Kuhar, M. J., 1979, Brain Res. 169:1–9.PubMedGoogle Scholar
  161. 161.
    Nomura, Y., Oki, K., and Segawa, T., 1982, J. Neurochem. 38:902–908.PubMedGoogle Scholar
  162. 162.
    Govoni, S., Spano, P. F., and Trabucchi, M., J. Pharm. Pharmacol. 30:448–449.Google Scholar
  163. 163.
    Titeler, M., List, S., and Seeman, P., 1980, Commun. Psychopharmacol. 3:411–420.Google Scholar
  164. 164.
    List, S. J., and Seeman, P., 1982, J. Neurochem. 39:1363–1373.PubMedGoogle Scholar
  165. 165.
    Arana, G. W., Baldessarini, R. J., and Harding M., 1981, Biochem. Pharmacol. 30:3171–3179.PubMedGoogle Scholar
  166. 166.
    Sokoloff, P., Martres, M.-P., and Schwartz, J.-C., 1980, Nature 288:283–286.PubMedGoogle Scholar
  167. 167.
    Davis, A., Madras, B. K., and Seeman, P., 1982, Biochem. Pharmacol. 31:1183–1187.PubMedGoogle Scholar
  168. 168.
    Leff, S., Sibley, D. R., Hamblin, M., and Creese, I., 1982, Life Sci. 29:2081–2090.Google Scholar
  169. 169.
    Arana, G. W., Baldessarini, R. J., and Kula, N. S., 1982, Neuropharmacology 21:601–604.PubMedGoogle Scholar
  170. 170.
    Bacopoulos, N. G., 1981, Life Sci. 23:2407–2414.Google Scholar
  171. 171.
    Nagy, J. I., Lee, T., Seeman, P., and Fibiger, H. C., 1978, Nature 274:278–281.PubMedGoogle Scholar
  172. 172.
    Leff, S. E., Hamblin, M. W., and Creese, I., 1982, Soc. Neurosci. Abstr. 8:719.Google Scholar
  173. 173.
    Nishikori, K., Noshiro, O., Sano, K., and Maeno, H., 1980, J. Biol. Chem. 255:10909–10915.PubMedGoogle Scholar
  174. 174.
    Madras, B. K., Davis, A., and Seeman, P., 1980, Soc. Neurosci. Abstr. 6:240:Google Scholar
  175. 175.
    Titeler, M., 1981, Biochem. Pharmacol. 30:3031–3037.PubMedGoogle Scholar
  176. 176.
    Hamblin, M. W., and Creese, I., 1982, Mol. Pharmacol. 21:44–51.PubMedGoogle Scholar
  177. 177.
    Lorez, H. P., and Burkard, W. P., 1979, Experientia 35:938.Google Scholar
  178. 178.
    Marchais, D., Tassin, J. P., and Bockaert, J., 1980, Brain Res. 183:235–240.PubMedGoogle Scholar
  179. 179.
    Titeler, M., and Seeman, P., 1978, Experientia 34:1490–1493.PubMedGoogle Scholar
  180. 180.
    Lee, T., and Seeman, P., 1979, Soc. Neurosci. Abstr. 5:653.Google Scholar
  181. 181.
    Peroutka, S. J., and Snyder, S. H., 1980, Am. J. Psychiatry 137:1518–1522.PubMedGoogle Scholar
  182. 182.
    Creese, I., Burt, D. R., and Snyder, S. H., 1978, Handbook of Psychopharmacology ,(L. L. Iversen, S. D. Iversen, and S. H. Snyder, eds.), Plenum Press, New York, pp. 37–89.Google Scholar
  183. 183.
    Seeman, P., Wong, M., and Tedesco, J., 1975, Soc. Neurosci. Abstr. 1:405.Google Scholar
  184. 184.
    Madras, B. K., Davis, A., and Seeman, P., 1982, Eur. J. Pharmacol. 78:431–438.PubMedGoogle Scholar
  185. 185.
    Davis, A., Madras, B., and Seeman, P., 1981, Eur. J. Pharmacol. 70:321–329.PubMedGoogle Scholar
  186. 186.
    Hartley, E. J., and Seeman, P., 1978, Life Sci. 23:513–518.PubMedGoogle Scholar
  187. 187.
    Creese, I., Stewart, K., and Snyder, S. H., 1979, Eur. J. Pharmacol. 60:55–66.PubMedGoogle Scholar
  188. 188.
    Caron, M. C., Beaulieu, M., Raymond, V., Gagne, B., Drouin, J., Lefkowitz, R. J., and Labrie, F., 1978, J. Biol. Chem. 253:2244–2253.PubMedGoogle Scholar
  189. 189.
    Limbird, L. E., Gill, D. M., and Lefkowitz, R. J., 1980, Proc. Natl. Acad. Sci. 77:775–779.PubMedGoogle Scholar
  190. 190.
    De Lean, A., Kilpatrick, B. F., and Caron, M. G., 1982, Endocrinology 110:1064–1066.PubMedGoogle Scholar
  191. 191.
    George, S. R., Wregget, K. A., and Seeman, P., 1982, Soc. Neurosci. Abstr. 8:720.Google Scholar
  192. 192.
    Onali, P., Schwartz, J. P., and Costa, E., 1981, Proc. Natl. Acad. Sci. U.S.A. 78:6531–6534.PubMedGoogle Scholar
  193. 193.
    Cote, T. E., Greive, C. W., Tsuruta, K., Stoof, J. C., Eskay, R. L., and Kebabian, J. W., 1982, Endocrinology 110:812–819.PubMedGoogle Scholar
  194. 194.
    Brown, J. H., and Makman, M. H., 1972, Proc. Natl. Acad. Sci. U.S.A. 69:539–543.PubMedGoogle Scholar
  195. 195.
    Brown, J. H., and Makman, M. H., 1973, J. Neurochem. 21:447–479.Google Scholar
  196. 196.
    Makman, M. H., Dvorkin, B., Horowitz, S. G., and Thal, L. J., 1980, Brain Res. 194:403–418.PubMedGoogle Scholar
  197. 197.
    Demenge, P., Mouchet, P., Guerin, B., and Feuerstein, C., 1981, J. Neurochem. 37:53–59.PubMedGoogle Scholar
  198. 198.
    Goldberg, L. I., Volkman, P. H., and Kohli, J. D., 1978, Annu. Rev. Pharmacol. Toxicol. 18:57–79.PubMedGoogle Scholar
  199. 199.
    Goldberg, L. I., and Toda, N., 1975, Circ. Res. 36:197–1102.Google Scholar
  200. 200.
    Toda, N., and Goldberg, L. I., 1975, Cardiovasc. Res. 9:384–89.PubMedGoogle Scholar
  201. 201.
    Goldberg, L. I., Kohli, J. D., Katake, A. N. and Volkman, P. H. 1978, Fed. Proc. 37:2396–2402.PubMedGoogle Scholar
  202. 202.
    Goldberg, L. I., Kohli, J. D., Kotake, A. N., and Volkman, P. H., 1977, Adv. Biochem. Pharmacol. 16:251–256.Google Scholar
  203. 203.
    Attie, M. F., Brown, E. M., Gardner, D. G., Spiegel, A. M., and Aurbach, G. D., 1980, Endocrinology 107:1776–1781.PubMedGoogle Scholar
  204. 204.
    Lee, T., and Seeman, P., 1980, Am. J. Psychiatry 137:191–197.PubMedGoogle Scholar
  205. 205.
    Owen, F., Crow, T. J., Poulter, M., Longden, A., and Riley, G. J., 1978, Lancet 2:223–226.PubMedGoogle Scholar
  206. 206.
    Cross, A. J., Crow, T., and Owen, F., 1981, Psychopharmacology 74:122–124.PubMedGoogle Scholar
  207. 207.
    Mackay, A. V. P., Bird, E. D., Spokes, E. G., Rosser, M., Iversen L. L., Creese, I., and Snyder, S. H., 1980, Lancet 2:915–916.PubMedGoogle Scholar
  208. 208.
    Olsen, R. W., Reisine, T. D., and Yamamura, H. I., 1980, Life Sci. 27:801–808.PubMedGoogle Scholar
  209. 209.
    Ezrin-Waters, C., Seeman, M. V., and Seeman, P., 1981, J. Clin. Psychiatry 42:16–22.PubMedGoogle Scholar
  210. 210.
    Baldessarini, R. J., and Tarsy, D., 1981, Annu. Rev. Neurosci. 3:23–41.Google Scholar
  211. 211.
    Tarsy, D., 1983, Clin. Neuropharmacology 6:91–99.Google Scholar
  212. 212.
    Richardson, M. A., and Craig, T. J., 1982, Am. J. Psychiatry 139:341–343.PubMedGoogle Scholar
  213. 213.
    Lee, T., Seeman, P., Rajput, A., Farley, I. J., and Hornykiewicz, O., 1978, Nature 278:59–61.Google Scholar
  214. 214.
    Rinne, U. K., Sonninen, V., and Laaksonen, H., 1979, Adv. Neurol. 24:259–274.Google Scholar
  215. 215.
    Reisine, T. D., Fields, J. Z., Yamamura, H. I., Bird, E. D., Spokes, E., Schreiner, P. S., and Enna, S. J., 1977, Life Sci. 21:335–344.PubMedGoogle Scholar
  216. 216.
    Hyttel, J., 1979, J. Neurochem. 33:641–646.PubMedGoogle Scholar
  217. 217.
    Tarsy, D., and Baldessarini, R. J., 1977, Biol. Psychiatry 12:431–450.PubMedGoogle Scholar
  218. 218.
    Costall, B., Naylor, R. J., and Owen, R. T., 1978, Eur. J. Pharmacol. 48:29–36.PubMedGoogle Scholar
  219. 219.
    Seeman, P., and List, S., 1982, Advances in Pharmacology and Therapeutics 11 ,Volume 2, (H. Yoshida, Y. Hagihara, and E. Ebashi, eds.), Pergamon Press, New York.Google Scholar
  220. 220.
    Baldessarini, R. J., and Tarsy, D., 1979, Int. Rev. Neurobiol. 2:1–45.Google Scholar
  221. 221.
    Scatton, B., 1977, Eur. J. Pharmacol. 46:363–369.PubMedGoogle Scholar
  222. 222.
    Muller, P., and Seeman, P., 1977, Life Sci. 21:1751–1758.PubMedGoogle Scholar
  223. 223.
    Owen, F., Cross, A. J., Waddington, J. L., Poulter, M., Gamble, S. J., and Crow, T. J., 1980, Life Sci. 26:55–59.PubMedGoogle Scholar
  224. 224.
    Hitri, A., Weiner, W. J., Borison, R. L., Diamond, B. I., Nausieda, P., and Klawans, H. L., 1978, Ann. Neurol. 3:134–140.PubMedGoogle Scholar
  225. 225.
    Fuxe, K., Ogren, S.-O., Hall, H., Agnati, L. F., Jonsson, G., and Gustafsson, J.-A., 1980, Adv. Biochem. Psychopharmacol. 24:193–206.PubMedGoogle Scholar
  226. 226.
    Cross, A. J., Crow, T. J., and Owen, F., 1979, Br. J. Pharmacol. 64:87P–88P.Google Scholar
  227. 227.
    Friend, W. C., Brown, G. M., Jawahir, G., Lee, T., and Seeman, P., 1978, Am. J. Psychiatry 135:839–841.PubMedGoogle Scholar
  228. 228.
    Thornburg, J. E., and Moore, K. E., 1975, J. Pharmacol. Exp. Ther. 192:42–49.PubMedGoogle Scholar
  229. 229.
    Skirboll, L. R., and Bunney, B. S., 1979, Life Sci. 25:1419–1434.PubMedGoogle Scholar
  230. 230.
    Ungerstedt, U., 1971, Acta Physiol. Scand. [Suppl.] 367:69–93.Google Scholar
  231. 231.
    Creese, I., Burt, D. R., and Snyder, S. H., 1977, Science 197:596–598.PubMedGoogle Scholar
  232. 232.
    Thai, L., Mishra, R. K., Gardner, E. L., Horowitz, S. G., Varmuza, S., and Makman, M. H., 1979, Brain Res. 170:381–386.Google Scholar
  233. 233.
    Staunton, D. A., Magistretti, P. J., Shoemaker, W. J., and Bloom, F. E., 1982, Brain Res. 232:391–400.PubMedGoogle Scholar
  234. 234.
    Staunton, D. A., Magistretti, P. J., Shoemaker, W. J., Deyo, S. N., and Bloom, F. E., 1982, Brain Res. 232:401–412.PubMedGoogle Scholar
  235. 235.
    Creese, I., and Sibley, D. R., 1981, Annu. Rev. Pharmacol. Toxicol. 21:359–391.Google Scholar
  236. 236.
    Mishra, R. K., Wong, Y.-W., Varmuza, S. L., and Tuff, L., 1978, Life Sci. 23:443–46.PubMedGoogle Scholar
  237. 237.
    Howlett, D. R., and Nahorski, S. R., 1979, Brain Res. 161:173–178.PubMedGoogle Scholar
  238. 238.
    Lew, J. Y., Nakamura, S., Battista, A. F., and Goldstein, M., 1979, Commun. Psycho pharmacol. 3:179–83.Google Scholar
  239. 239.
    Quik, M., and Iversen, L. L., 1978, Naunyn Schmeidebergs Arch. Pharmacol. 304:141–145.Google Scholar
  240. 240.
    Russell, P., and Madras, B. K., 1983, submitted.Google Scholar
  241. 241.
    Labrie, F., Di Paolo, T., Raymond, V., Ferland, L., and Beaulieu, M., 1980, Ergot Com pounds and Brain Function: Neuroendocrine and Neuropsychiatric Aspects (M. Goldstein, ed.), Raven Press, New York, p. 217.Google Scholar
  242. 242.
    Bedard, P. J., Langelier, P., Dankova, J., Villeneuve, A., Di Paolo, T., Barden, N., Labrie, F., Bossier, J. R., and Euvrard, C., 1979, Adv. Neurol. 24:411.Google Scholar
  243. 243.
    Di Paolo, T., Carmichael, R., Labrie, F., and Raynaud, J.-P., 1979, Mol. Cell. Endocrinol. 16:99–112.PubMedGoogle Scholar
  244. 244.
    Bedard, P., Dankova, J., Boucher, R., and Langelier, P., 1981, Can. J. Physiol. Pharmacol. 56:538–541.Google Scholar
  245. 245.
    Di Paolo, T., Payet, P., and Labrie, F., 1981, Eur. J. Pharmacol. 78:105–106.Google Scholar
  246. 246.
    Hruska, R. E., and Silbergeld, E. K., 1980, Eur. J. Pharmacol. 61:397–400.PubMedGoogle Scholar
  247. 247.
    Hruska, R. E., Pitman, K. T., Silbergeld, E. K., and Ludmer, L. M., 1982, Life Sci. 30:547–553.PubMedGoogle Scholar
  248. 248.
    Jenner, P., Rupniak, N. M. J., Hall, M. D., Dyer, R., Leigh, N., and Marsden, C. D., 1981, Eur. J. Pharmacol. 76:31–36.PubMedGoogle Scholar
  249. 249.
    Bowers, M. B., and Rozitis, A. 1976, Eur. J. Pharmacol. 39:109–115.PubMedGoogle Scholar
  250. 250.
    Chouinard, G., Annable, L., Jones, B. D., and Collu, R., 1981, Acta Psychiatr. Scand. 64:353–362.PubMedGoogle Scholar
  251. 251.
    Curry, S. H., Davis, J. M., Marshall, H. L., and Janowsky, D. S., 1970, Arch. Gen. Psychiatry 22:209–215.PubMedGoogle Scholar
  252. 252.
    Creese, I., and Snyder, S. H., 1977, Nature 270:180–182.PubMedGoogle Scholar
  253. 253.
    Davis, M. M., Erickson, S., and Dekirmenjian, H., 1978, Psychopharmacology: A Generation of Progress (M. A. Lipton, A. DiMascio, and K. F. Killiam, eds.), Raven Press, New York, pp. 905–916.Google Scholar
  254. 254.
    Cohen, B. M., Herschel, M., Miller, E. M., Mayberg, H., and Baldessarini, R., 1980, Neuropharmacology 19:663–668.PubMedGoogle Scholar
  255. 255.
    Cohen, B. M., Herschel, M., and Aoba, A., 1979, Psychiatry Res. 1:199–208.PubMedGoogle Scholar
  256. 256.
    Rosenblatt, J. E., Pert, C. B., Cobson, J., Van Kammen, D. P., Scott, R., and Bunney, W. E., Jr., 1979, Commun. Psychopharmacol. 3:153–168.PubMedGoogle Scholar
  257. 257.
    Cohen, B. M., and Lipinski, J. F., 1981, Neuroreceptors-Basic and Clinical Aspects (E. Usdin, W. E. Bunney, and J. M. Davis, eds.), John Wiley & Sons, New York, pp. 199–214.Google Scholar
  258. 258.
    Uzan, A., Phan, T., and Le Fur, G., 1981, J. Pharm. Pharmacol. 33:102–103.PubMedGoogle Scholar
  259. 259.
    Le Fur, G., Phan, T., and Uzan, A., 1980, Life Sci. 26:1139–1148.PubMedGoogle Scholar
  260. 260.
    Le Fur, G., Meininger, V., Phan, T., Gerard, A., Baulac, M., and Uzan, A., 1980, Life Sci. 21: 1587–1591.Google Scholar
  261. 261.
    Le Fur, G., Phan, T., Canton, T., Tur, C., and Uzan, A., 1981, Life Sci. 29:2737–2749.PubMedGoogle Scholar
  262. 262.
    Maloteaux, J. M., Waterkein, C., and Laduron, P. M., 1982, Arch. Int. Pharmacodyn. Ther. 258:174–176.PubMedGoogle Scholar
  263. 263.
    Fleminger, S., Jenner, P., and Marsden, C. D., 1982, J. Pharmacol. 34:658–663.Google Scholar
  264. 264.
    Madras, B. K., Blaschuk, K., Scully, K., Tang, S. W., 1983, Soc. Neurosci. Abstr. 9:1054.Google Scholar
  265. 265.
    Strauss, W. L., Ghai, G., Fraser, C. H., and Venter, J. C., 1979, Arch. Biochem. Biophys. 196:566–573.PubMedGoogle Scholar
  266. 266.
    Ruegg, V. T., Hiller, J. M., and Simon, S. J., 1980, Eur. J. Pharmacol. 64:367–368.PubMedGoogle Scholar
  267. 267.
    Gorissen, H., and Laduron, P., 1979, Nature 279:72–74.PubMedGoogle Scholar
  268. 268.
    Madras, B. K., Davis, A., Kunashko, P., and Seeman, P., 1980, Psychopharmacology and Biochemistry of Neurotransmitter Receptors ,(H. I. Yamamura, R. W. Olsen, and E. Usdin, eds.), Elsevier/North Holland, New York, pp. 411–419.Google Scholar
  269. 269.
    Lerner, M. H., Rosengarten, H., and Friedhoff, A. J., 1981, Life Sci. 29:2367–2374.PubMedGoogle Scholar
  270. 270.
    Lew, J. Y., Fong, J. C., and Goldstein, M., 1981, Eur. J. Pharmacol. 72:403–405.PubMedGoogle Scholar
  271. 271.
    Gorissen, H., Ilien, B., Aerts, G., and Laduron, P., 1980, FEBS Lett. 121:133–138.PubMedGoogle Scholar
  272. 272.
    Clement-Cormier, Y. C., Meyerson, L. R., and Mclsaac, A., 1980, Biochem. Pharmacol. 29:2009–2016.PubMedGoogle Scholar
  273. 273.
    Gorissen, H., and Laduron, P. M., 1978, Life Sci. 23:575–580.PubMedGoogle Scholar
  274. 274.
    Chan, B., Madras, B. K., Davis, A., and Seeman, P., 1981, Eur. J. Pharmacol. 74:53–59.PubMedGoogle Scholar
  275. 275.
    Varmuza, S., and Mishra, R. K., 1981, Pharmacol. Res. Commun. 13:587–605.PubMedGoogle Scholar
  276. 276.
    Lo, M. M. S., Strittmatter, S. M., and Snyder, S. H., 1982, Proc. Natl. Acad. Sci. 79:680–684.PubMedGoogle Scholar
  277. 277.
    Chan, B., Seeman, P., Davis, A., and Madras, B. K., 1982, Eur. J. Pharmacol. 81:111–116.PubMedGoogle Scholar
  278. 278.
    Freedman, J. E., and Snyder, S. H., 1981, J. Biol. Chem. 24:13172–13179.Google Scholar
  279. 279.
    Lilly, L., Magnan, J., Davis, A., and Seeman, P., 1982, Soc. Neurosci. Abstr. 8:719.Google Scholar
  280. 280.
    Clement-Cormier, Y. C., and Kendrick, P. E., 1981, Biochem. Pharmacol. 16:2197–2202.Google Scholar
  281. 281.
    Lilly, L., Davis, A., Madras, B. K., Fraser, C. H., Venter, J. C., and Seeman, P., 1981, Soc. Neurosci. Abstr. 7:10.Google Scholar
  282. 282.
    Madras, B. K., Davis, L., Lilly, C., Fraser, C., Venter, J. C., and Seeman, P., 1981, Soc. Neurosci. Abstr. 7:10.Google Scholar
  283. 283.
    Creese, I., Morrow, A. L., Leff, S. E., Sibley, D. R., and Hamblin, M. W., 1982, Int. Rev. Neurobiol. 23:255–301.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1984

Authors and Affiliations

  • Bertha Kalifon Madras
    • 1
  1. 1.Psychopharmacology SectionClarke Institute of PsychiatryTorontoCanada

Personalised recommendations